ArticleCureus2025
Baseline Patient-Reported Health Status Predicts Hospitalization Duration and Cost in Chronic Heart Failure.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study examined the significance and independence of patient-reported outcomes (PROs) in predicting hospitalization costs and duration among patients with chronic heart failure (CHF). This observational cross-sectional study included all adult patients with a physician-confirmed diagnosis of CHF who were admitted to the cardiology department of a university emergency hospital in Bucharest, Romania, between July and September 2024. Upon admission, patients completed the validated Romanian version of the 12-item Kansas City Cardiomyopathy Questionnaire (KCCQ) and underwent a clinical interview, physical examination, blood sampling, and transthoracic echocardiography. The primary outcomes were total hospitalization cost and length of stay, whereas the KCCQ Overall Summary Score (KCCQ-OSS) served as the primary predictor in generalized linear models adjusted for potential confounders. The study included 171 patients with a mean age of 73.5 years, of whom 55.0% were women. The median total hospitalization cost was €1,513 per patient, and the mean length of stay was 8.7 days. Each 10-point decrease in KCCQ-OSS was independently associated with a 9.5% increase in expected hospitalization duration, whereas each 10-point increase in KCCQ-OSS was independently associated with a 5.1% increase in expected hospitalization cost, likely reflecting elective procedures in healthier patients. The latter finding likely reflects that patients with better baseline health status were more often selected for elective or interventional procedures, which increased costs despite shorter stays. These results demonstrate that the KCCQ-OSS is an independent predictor of both hospitalization cost and duration in CHF, within the limits of the study (single-center, small sample). Incorporating KCCQ assessment into routine practice may enable earlier identification of high-risk, high-cost patients, inform resource allocation, and enhance patient-centered, value-based management strategies for CHF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.